2024-04-25 23:52:09 ET
PTC Therapeutics, Inc. (PTCT)
Q1 2024 Earnings Conference Call
April 25, 2024 16:30 ET
Company Participants
Jane Hanlon - Associate Director of Investor Relations
Matthew Klein - Chief Executive Officer
Eric Pauwels - Chief Business Officer
Kylie O’Keefe - Chief Commercial Officer
Pierre Gravier - Chief Financial Officer
Conference Call Participants
Kristen Kluska - Cantor Fitzgerald
Eric Joseph - JPMorgan
Kelly Shi - Jefferies
Samantha Corwin - William Blair
Joseph Thome - TD Cowen
Gena Wang - Barclays
Jeff Hung - Morgan Stanley
David Lebowitz - Citi
Danielle Brill - Raymond James
Tazeen Ahmad - Bank of America
Paul Choi - Goldman Sachs
Presentation
Operator
Good day and thank you for standing by. Welcome to PTC First Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Jane Hanlon, Associate Director of Investor Relations. Please go ahead.
Jane Hanlon
Good afternoon and thank you for joining us today to discuss PTC Therapeutics first quarter 2024 corporate update and financial results. I'm joined today by our Chief Executive Officer, Dr. Matthew Klein, our Chief Business Officer, Eric Pauwels; our Chief Commercial Officer, Kylie O'Keefe; and our Chief Financial Officer, Pierre Gravier.
Today's call will include forward-looking statements based on our current expectations. Please take a moment to review the slide posted on our Investor Relations website in conjunction with the call which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements as such statements are subject to risks that can materially and adversely affect our business and results of operations. For a detailed description of applicable risks and uncertainties, we encourage you to review the company's most recent quarterly report on Form 10-Q and annual report on Form 10-K filed with the Securities and Exchange Commission as well as the company's other SEC filings....
Read the full article on Seeking Alpha
For further details see:
PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript